May 09, 2025 OcuSciences Gets U.S. Food and Drug Administration Clearance for Retina Health Assessment Device Optometric Management
May 08, 2025 Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 DED Chamber Trial of Reproxalap Ophthalmology Management
May 09, 2025 OcuSciences Gets U.S. Food and Drug Administration Clearance for Retina Health Assessment Device Optometric Management
May 08, 2025 Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 DED Chamber Trial of Reproxalap Ophthalmology Management
May 08, 2025 Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 DED Chamber Trial of Reproxalap Ophthalmology Management
May 08, 2025 Data Presented at ARVO Highlight Licaminlimab in the Treatment of DED Ophthalmology Management
April 28, 2025 Long-Term Stability of Incisions With Dual-Pulse Femtosecond Laser for Astigmatism Ophthalmology Management